- A double-blind, crossover, randomized comparison of granisetron and ramosetron for the prevention of acute and delayed cisplatin-induced emesis in patients with gastrointestinal cancer: is patient preference a better primary endpoint? Koizumi, W., Tanabe, S., Nagaba, S., Higuchi, K., Nakayama, N., Saigenji, K., Nonaka, M., Yago, K. Chemotherapy. (2003)